Literature DB >> 22592569

Antioxidant treatment prevents cognitive impairment and oxidative damage in pneumococcal meningitis survivor rats.

Tatiana Barichello1, Ana Lucia B Santos, Geovana D Savi, Jaqueline S Generoso, Paola Otaran, Cleonice M Michelon, Amanda V Steckert, Francielle Mina, Clarissa M Comim, Felipe Dal-Pizzol, João Quevedo.   

Abstract

Pneumococcal meningitis is associated with the highest fatality case ratios in the world. Most of patients that survive present neurologic sequelae at later times as well as biochemicals alterations such as oxidative stress in both earlier and later times after central nervous system infection. In this context, we evaluated the effect of antioxidant treatment on memory and oxidative parameters in the hippocampus of meningitis survivor rats 10 days after infection. To this aim, the animals underwent a magna cistern tap receiving either 10 μL sterile saline as a placebo or an equivalent volume of a Streptococcus pneumoniae suspension at the concentration 5x10(9) cfu/mL. The animals submitted to meningitis were divided into the following groups: 1) treated with antibiotic, 2) treated with basic support plus N-acetylcysteine, 3) treated with basic support plus deferoxamine, 4) treated with basic support plus N-acetylcysteine and deferoxamine, or 5) treated with N-acetylcysteine plus deferoxamine. Ten days after meningitis, the animals underwent inhibitory avoidance and habituation to an open field tasks and, immediately after, were assessed for oxidative damage in the hippocampus and cortex. The meningitis group showed significantly decreased performance in latency retention compared with the sham group in the inhibitory avoidance task. In the open-field task, the meningitis group presented memory impairment after meningitis. All these memory impairments were prevented by N-acetylcysteine plus deferoxamine with or without basic support and its isolate use. In addition, there was an increase of lipid phosphorylation in cortex and hippocampus and all the combined antioxidants attenuated lipid phosphorylation in both structures. On the other hand, there was an increase of protein phosphorylation in cortex and N-acetylcysteine plus deferoxamine with or without basic support prevented it. Thus, we hypothesize that oxidative stress may be related to cognitive impairment in pneumococcal meningitis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22592569     DOI: 10.1007/s11011-012-9315-9

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  38 in total

Review 1.  Biological properties of pneumolysin.

Authors:  T J Mitchell; P W Andrew
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

2.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

Authors:  M Tepel; M van der Giet; C Schwarzfeld; U Laufer; D Liermann; W Zidek
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

3.  Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.

Authors:  Denis Grandgirard; Christian Schürch; Philippe Cottagnoud; Stephen L Leib
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

4.  Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use.

Authors:  Stephanie J Schrag; James L Hadler; Kathryn E Arnold; Patricia Martell-Cleary; Arthur Reingold; Anne Schuchat
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

5.  TNF-alpha, IL-1beta, IL-6, and cinc-1 levels in rat brain after meningitis induced by Streptococcus pneumoniae.

Authors:  Tatiana Barichello; Ivonete dos Santos; Geovana D Savi; Lutiana R Simões; Tiago Silvestre; Clarissa M Comim; Daniela Sachs; Mauro M Teixeira; Antonio L Teixeira; João Quevedo
Journal:  J Neuroimmunol       Date:  2010-03-03       Impact factor: 3.478

6.  Dexamethasone decreases neurological sequelae and caspase activity.

Authors:  Jose Irazuzta; Robert K Pretzlaff; Gabrielle DeCourten-Myers; Frank Zemlan; Basilia Zingarelli
Journal:  Intensive Care Med       Date:  2004-10-16       Impact factor: 17.440

7.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

8.  Cognitive outcome in adults after bacterial meningitis.

Authors:  Martine Hoogman; Diederik van de Beek; Martijn Weisfelt; Jan de Gans; Ben Schmand
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-12       Impact factor: 10.154

9.  Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats.

Authors:  H W Pfister; U Koedel; S Lorenzl; A Tomasz
Journal:  Stroke       Date:  1992-12       Impact factor: 7.914

10.  Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group.

Authors:  E R Wald; S L Kaplan; E O Mason; D Sabo; L Ross; M Arditi; B L Wiedermann; W Barson; K S Kim; R Yogov
Journal:  Pediatrics       Date:  1995-01       Impact factor: 7.124

View more
  8 in total

Review 1.  Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.

Authors:  Robert A Floyd; Hugo C Castro Faria Neto; Guy A Zimmerman; Kenneth Hensley; Rheal A Towner
Journal:  Free Radic Biol Med       Date:  2013-02-16       Impact factor: 7.376

Review 2.  Role of Microglial Activation in the Pathophysiology of Bacterial Meningitis.

Authors:  Tatiana Barichello; Jaqueline S Generoso; Lutiana R Simões; Jessica A Goularte; Fabricia Petronilho; Priyanka Saigal; Marwa Badawy; João Quevedo
Journal:  Mol Neurobiol       Date:  2015-03-07       Impact factor: 5.590

Review 3.  Does Infection-Induced Immune Activation Contribute to Dementia?

Authors:  Tatiana Barichello; Jaqueline S Generoso; Jessica A Goularte; Allan Collodel; Meagan R Pitcher; Lutiana R Simões; João Quevedo; Felipe Dal-Pizzol
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 4.  Current Understanding of Long-Term Cognitive Impairment After Sepsis.

Authors:  Ying Li; Muhuo Ji; Jianjun Yang
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

5.  Edaravone attenuates hippocampal damage in an infant mouse model of pneumococcal meningitis by reducing HMGB1 and iNOS expression via the Nrf2/HO-1 pathway.

Authors:  Zheng Li; Qian-Qian Ma; Yan Yan; Feng-Dan Xu; Xiao-Ying Zhang; Wei-Qin Zhou; Zhi-Chun Feng
Journal:  Acta Pharmacol Sin       Date:  2016-08-29       Impact factor: 6.150

6.  Cerebroprotective Effects of 2-Ethyl-6-methyl-3-hydroxypyridine-2,6-dichlorophenyl(amino)phenylethanoic Acid in the Treatment of Purulent Meningitis.

Authors:  Alina Agarkova; Mikhail Pokrovskii; Pavel Kolesnichenko; Vladimir Gureev; Oleg Gudyrev; Anna Peresypkina; Vladislav Soldatov; Arkadii Nesterov; Tatyana Denisyuk; Mikhail Korokin
Journal:  Biomedicines       Date:  2021-03-11

Review 7.  Role of oxidative stress in the pathophysiology of pneumococcal meningitis.

Authors:  Tatiana Barichello; Jaqueline S Generoso; Lutiana R Simões; Samuel G Elias; João Quevedo
Journal:  Oxid Med Cell Longev       Date:  2013-05-09       Impact factor: 6.543

8.  Neuroinflammation trajectories precede cognitive impairment after experimental meningitis-evidence from an in vivo PET study.

Authors:  Vijayasree V Giridharan; Allan Collodel; Jaqueline S Generoso; Giselli Scaini; Rico Wassather; Sudhakar Selvaraj; Rodrigo Hasbun; Felipe Dal-Pizzol; Fabricia Petronilho; Tatiana Barichello
Journal:  J Neuroinflammation       Date:  2020-01-04       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.